Top 10 Pre-Market Analyst Calls (AKAM, MO, AZN, GSK, HES, LVLT, PEP, PIR, UBS, VMW)

Investing

Published: April 1, 2008 6:39 am

These aren’t the only impact analyst calls this morning, but these are the ones we are focusing the Tuesday in pre-market trading hours:

Akamai Tech (NASDAQ: AKAM) Raised to Buy from Neutral at Piper Jaffray.
Altria (NYSE: MO) Cut to Equalweight from Overweight at Morgan Stanley.
AstraZeneca (NYSE: AZN) raised to Neutral at JPMorgan.
GlaxoSmithKline (NYSE: GSK) Started as Buy at ING.
Hess (NYSE: HES) Raised To Outperform From Market Perform at FBR.
Level 3 Communications (NASDAQ: LVLT) Started As Underperform at Wachovia.
PepsiCo (NYSE: PEP) Cut To Neutral From Buy at Goldman Sachs.
Pier 1 Imports (NYSE: PIR) Raised To Buy From Hold at Deutsche Bank.
UBS (NYSE: UBS) Raised To Buy at Deutsche Bank.
VMware (NYSE: VMW) Raised To Outperform From Market Perform at Wachovia.

Jon C. Ogg
April 1, 2008

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.